SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601485-21-000023
Filing Date
2021-05-18
Accepted
2021-05-18 16:04:40
Documents
1
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162136823397793.html 4  
1 FORM 4 wf-form4_162136823397793.xml 4 3498
  Complete submission text file 0001601485-21-000023.txt   4888
Mailing Address C/O ADAMAS PHARMACEUTICALS INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address
Rhodes Jennifer J (Reporting) CIK: 0001568249 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 21935948

Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations